Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
Guangyu Zhou, Qi Zhao
International Journal of Biological Sciences (2020) Vol. 16, Iss. 10, pp. 1718-1723
Open Access | Times Cited: 274

Showing 1-25 of 274 citing articles:

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
Yuan Huang, Chan Yang, Xin-feng Xu, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 9, pp. 1141-1149
Open Access | Times Cited: 2138
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
Christopher O. Barnes, Anthony P. West, Kathryn E. Huey‐Tubman, et al.
Cell (2020) Vol. 182, Iss. 4, pp. 828-842.e16
Open Access | Times Cited: 823
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Yung-Fang Tu, Chian‐Shiu Chien, Aliaksandr A. Yarmishyn, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2657-2657
Open Access | Times Cited: 708
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
Nadin Younes, Duaa W. Al‐Sadeq, Hadeel Al-Jighefee, et al.
Viruses (2020) Vol. 12, Iss. 6, pp. 582-582
Open Access | Times Cited: 405
Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review)
Daniela Călina, Anca Oana Docea, Demetrios Petrakis, et al.
International Journal of Molecular Medicine (2020) Vol. 46, Iss. 1, pp. 3-16
Open Access | Times Cited: 318
COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies
Vrishali S. Salian, Jessica Wright, Peter T. Vedell, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 3, pp. 754-771
Closed Access | Times Cited: 296
A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin
Anwarul Hasan, Bilal Ahamad Paray, Arif Hussain, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 8, pp. 3025-3033
Open Access | Times Cited: 290
A serological survey of SARS-CoV-2 in cat in Wuhan
Qiang Zhang, Huajun Zhang, Jindong Gao, et al.
Emerging Microbes & Infections (2020) Vol. 9, Iss. 1, pp. 2013-2019
Open Access | Times Cited: 290
Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review
Satarudra Prakash Singh, Manisha Pritam, Brijesh Pandey, et al.
Journal of Medical Virology (2020) Vol. 93, Iss. 1, pp. 275-299
Open Access | Times Cited: 156
S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates
Joshua G. Liang, Danmei Su, Tian‐Zhang Song, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 155
COVID-19: Progress in diagnostics, therapy and vaccination
Xue Liu, Chao Liu, Gang Liu, et al.
Theranostics (2020) Vol. 10, Iss. 17, pp. 7821-7835
Open Access | Times Cited: 148
Clinical performance of different SARS‐CoV‐2 IgG antibody tests
Niko Kohmer, Sandra Westhaus, Cornelia Rühl, et al.
Journal of Medical Virology (2020) Vol. 92, Iss. 10, pp. 2243-2247
Open Access | Times Cited: 145
High neutralizing antibody titer in intensive care unit patients with COVID-19
Li Liu, Kelvin Kai‐Wang To, Kwok‐Hung Chan, et al.
Emerging Microbes & Infections (2020) Vol. 9, Iss. 1, pp. 1664-1670
Open Access | Times Cited: 145
Artificial intelligence in the diagnosis of COVID-19: challenges and perspectives
Shigao Huang, Jie Yang, Simon Fong, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 6, pp. 1581-1587
Open Access | Times Cited: 114
Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
Hylemariam Mihiretie Mengist, Arnaud John Kombe Kombe, Daniel Mekonnen, et al.
Seminars in Immunology (2021) Vol. 55, pp. 101533-101533
Open Access | Times Cited: 105
COVID-19: Mechanisms of Vaccination and Immunity
Daniel E. Speiser, Martin F. Bachmann
Vaccines (2020) Vol. 8, Iss. 3, pp. 404-404
Open Access | Times Cited: 118
SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors
Sarah E. Benner, Eshan U. Patel, Oliver Laeyendecker, et al.
The Journal of Infectious Diseases (2020) Vol. 222, Iss. 12, pp. 1974-1984
Open Access | Times Cited: 112
Dynamics of Population Immunity Due to the Herd Effect in the COVID-19 Pandemic
Vicente Javier Clemente‐Suárez, Alberto J. Hormeño-Holgado, Manuel Jiménez, et al.
Vaccines (2020) Vol. 8, Iss. 2, pp. 236-236
Open Access | Times Cited: 110
Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines
Hsin‐I Shih, Chi-Jung Wu, Yi‐Fang Tu, et al.
Biomedical Journal (2020) Vol. 43, Iss. 4, pp. 341-354
Open Access | Times Cited: 106
Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site
Umesh Kalathiya, Monikaben Padariya, Marcos Yébenes Mayordomo, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 5, pp. 1473-1473
Open Access | Times Cited: 95
Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions
Edem Gavor, Yeu Khai Choong, Shi Yin Er, et al.
Trends in Immunology (2020) Vol. 41, Iss. 11, pp. 1006-1022
Open Access | Times Cited: 95
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations
Federico Bertoglio, Viola Fühner, Maximilian Ruschig, et al.
Cell Reports (2021) Vol. 36, Iss. 4, pp. 109433-109433
Open Access | Times Cited: 95
The global battle against SARS-CoV-2 and COVID-19
Chu-Xia Deng
International Journal of Biological Sciences (2020) Vol. 16, Iss. 10, pp. 1676-1677
Open Access | Times Cited: 92
Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
PJ Klasse, John P. Moore
eLife (2020) Vol. 9
Open Access | Times Cited: 91
Advances in gene-based vaccine platforms to address the COVID-19 pandemic
Deborah Pushparajah, Salma Jimenez, Shirley Wong, et al.
Advanced Drug Delivery Reviews (2021) Vol. 170, pp. 113-141
Open Access | Times Cited: 91
Page 1 - Next Page

Scroll to top